New photochromic foldable intraocular lens: Preliminary study of feasibility and biocompatibility

Characterization of a photochromic intraocular lens

We demonstrate an optical setup for characterization of a photochromic intraocular lens and present first measurement results of the kinetic properties and relative spectral transmittance of this photochromic lens. The lens showed a main absorption spectrum with a center wavelength of λ(c)=405 nm and a minimum relative transmission of 74% in the activated state. The coloring and bleaching times were within the manufacturer-provided specification of approximately 10 s for coloring and 30 s for bleaching.

Photochromic dynamics of ophthalmic lenses

We describe and characterize a straightforward test setup for characterizing temporal and spectral dynamics of photochromic spectacle materials. Three measurement examples of contemporary silicate and organic photochromic spectacles are provided. The setup showed a good absolute accuracy of ≤5% of the luminous transmittance (τ(v)) and repeatability of better than 3%. The samples showed different fading times. The sample with the highest dynamic range was the slowest and showed a noticeable change in the transmission spectra during deactivation. The silicate had the lowest dynamic range but also the most homogeneous transmission spectra throughout activation and deactivation. The proposed test device provided accurate results for spectral and temporal dynamics of photochromic materials under realistic conditions.

Comparison of photochromic, yellow, and clear intraocular lenses in human eyes under photopic and mesopic lighting conditions

PURPOSE

To evaluate the results of the first blue light-filtering photochromic intraocular lens (IOL) and compare them with those of a regular yellow blue light-filtering IOL and a clear ultraviolet-filtering IOL in human eyes under various lighting conditions.

SETTING

Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing, China.

DESIGN

Prospective comparative clinical study.

METHODS

This study evaluated eyes that had implantation of 1 of the following 3 IOLs: photochromic Aurium Matrix acrylic, model 400; yellow AF-1 (UY); or clear MC611MI. All eyes were followed for 3 months. The uncorrected (UDVA) and corrected (CDVA) distance visual acuities, contrast vision (lighting 400 lux, 30 lux, 5 lux), contrast sensitivity, color vision (Farnsworth-Munsell 100-hue test under 400 lux, 30 lux), and patient questionnaire responses were evaluated.

RESULTS

The photochromic IOL group comprised 39 eyes; the yellow IOL group, 41 eyes; and the clear IOL group, 38 eyes. There were no significant differences between the 3 IOLs in UDVA, CDVA, contrast sensitivity, or questionnaire responses. The photochromic group had significantly better color vision than the yellow IOL group at 30 lux and better contrast vision at 5% contrast (P < .05); however, there were no significant differences between the photochromic IOL group and the clear IOL group (P > .05).

CONCLUSION

The photochromic blue light-filtering IOL performed as well as the yellow and clear IOLs under photopic conditions. Under mesopic conditions, the yellow IOL gave poor color vision and contrast sensitivity.

Accelerated 20-year sunlight exposure simulation of a photochromic foldable intraocular lens in a rabbit model

PURPOSE

To assess the long-term biocompatibility and photochromic stability of a new photochromic hydrophobic acrylic intraocular lens (IOL) under extended ultraviolet (UV) light exposure.

SETTING

John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.

DESIGN

Experimental study.

METHODS

A Matrix Aurium photochromic IOL was implanted in right eyes and a Matrix Acrylic IOL without photochromic properties (n = 6) or a single-piece AcrySof Natural SN60AT IOL (n = 5) in left eyes of 11 New Zealand rabbits. The rabbits were exposed to a UV light source of 5 mW/cm(2) for 3 hours during every 8-hour period, equivalent to 9 hours a day, and followed for up to 12 months. The photochromic changes were evaluated during slitlamp examination by shining a penlight UV source in the right eye. After the rabbits were humanely killed and the eyes enucleated, study and control IOLs were explanted and evaluated in vitro on UV exposure and studied histopathologically.

RESULTS

The photochromic IOL was as biocompatible as the control IOLs after 12 months under conditions simulating at least 20 years of UV exposure. In vitro evaluation confirmed the retained optical properties, with photochromic changes observed within 7 seconds of UV exposure. The rabbit eyes had clinical and histopathological changes expected in this model with a 12-month follow-up.

CONCLUSIONS

The new photochromic IOL turned yellow only on exposure to UV light. The photochromic changes were reversible, reproducible, and stable over time. The IOL was biocompatible with up to 12 months of accelerated UV exposure simulation.

Color discrimination by patients with different types of light-filtering intraocular lenses

PURPOSE

To evaluate photopic and mesopic color discrimination in patients with different types of light-filtering intraocular lenses (IOLs).

SETTING

Peking University Third Hospital, Peking University Eye Center, Beijing, China.

METHODS

Cataract patients with different types of IOLs were enrolled 3 months postoperatively. Overall and partial color discrimination under photopic (1000 lux) and mesopic (40 lux) conditions were evaluated with the Farnsworth-Munsell (FM) 100-hue test. Corrected distance visual acuity (CDVA) was tested under both conditions. Subjective visual quality was assessed with the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25).

RESULTS

The study evaluated 43 patients with a blue light-filtering IOL (15 photochromic, 13 yellow tinted) or an IOL filtering ultraviolet light only (n = 15). The difference in the FM 100-hue total error scores under photopic or mesopic conditions was not statistically significant between groups. There were no statistically significant differences in partial error scores in the 10 bands of the FM 100-hue color circle under photopic conditions. Under mesopic condition, there were statistically significant differences in partial error scores in the green to blue-green band (color caps 36 to 46) and the blue-green to blue band (color caps 46 to 54) (P = .005 and P = .030, respectively). There were no statistically significant differences in mean overall or subheading NEI VFQ-25 scores.

CONCLUSIONS

Filtering blue lights under mesopic conditions seemed to modify color discrimination in the green-to-blue bands postoperatively. The modification did not disturb overall color discrimination or cause subjective discomfort.

Biocompatibility of intraocular lens materials

PURPOSE OF REVIEW

To provide an update on currently available materials used in the manufacture of intraocular lenses, as well as new materials under development, especially with regard to their uveal and capsular biocompatibility.

RECENT FINDINGS

The biocompatibility of intraocular lens materials should be assessed in terms of uveal biocompatibility, related to the inflammatory foreign-body reaction of the eye against the implant, as well as in terms of capsular biocompatibility, determined by the relationship of the intraocular lens with remaining lens epithelial cells within the capsular bag. This situation may result in different entities, e.g. anterior capsule opacification, interlenticular opacification (between piggyback intraocular lenses), posterior capsule opacification and lens epithelial cell ongrowth. Reports on intraocular lens opacification suggest that the potential to calcify should also be taken into consideration when evaluating the long-term biocompatibility of a new material.

SUMMARY

Intraocular lenses are being progressively implanted in much earlier stages of life (refractive lens exchange, pediatric implantation) and are expected to remain in the intraocular environment for many decades. Materials used in intraocular lens manufacture should, therefore, insure long-term uveal and capsular biocompatibility, as well as ultimate transparency after implantation.